Employment Agreements in the Biotechnology Industry

5,496 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (9 contracts)
4D Molecular Therapeutics Inc (1)
89bio, Inc. (10)
ABEONA THERAPEUTICS INC. (3)
ACADIA PHARMACEUTICALS INC (8)
ACCELERON PHARMA INC (12)
Achaogen, Inc. (1)
ACHIEVE LIFE SCIENCES, INC. (12)
Acorda Therapeutics (16)
Actinium Pharmaceuticals, Inc. (9)
Acumen Pharmaceuticals, Inc. (8)
Acurx Pharmaceuticals, LLC (3)
Adagio Therapeutics, Inc. (22)
Adamas Pharmaceuticals Inc (1)
Adaptimmune Therapeutics PLC (12)
Adhera Therapeutics, Inc. (18)
ADiTx Therapeutics, Inc. (7)
ADMA BIOLOGICS, INC. (12)
ADURO BIOTECH, INC. (10)
Advaxis, Inc. (11)
Adverum Biotechnologies, Inc. (14)
Aeglea BioTherapeutics, Inc. (1)
Aerovate Therapeutics, Inc. (4)
AGENUS INC (14)
AgeX Therapeutics, Inc. (1)
AILERON THERAPEUTICS INC (7)
Aimmune Therapeutics, Inc. (11)
Akebia Therapeutics, Inc. (5)
Akero Therapeutics, Inc. (3)
Akouos, Inc. (4)
ALBIREO PHARMA, INC. (31)
Alexion Pharmaceuticals (29)
Aligos Therapeutics, Inc. (8)
Alkermes plc. (9)
Allakos Inc. (6)
Allarity Therapeutics, Inc. (6)
Allena Pharmaceuticals, Inc. (5)
Alliqua BioMedical, Inc. (13)
Allogene Therapeutics, Inc. (9)
Allovir, Inc. (6)
ALNYLAM PHARMACEUTICALS, INC. (2)
Alpha Healthcare Acquisition Corp. (7)
ALPINE IMMUNE SCIENCES, INC. (27)
Altimmune, Inc. (22)
ALX ONCOLOGY HOLDINGS INC (2)
Alzamend Neuro, Inc. (1)
AMARILLO BIOSCIENCES INC (11)
AMARIN CORP PLC (8)
Amgen Inc. (1)
AMICUS THERAPEUTICS, INC. (26)
AmpliPhi Biosciences Corp (11)
Amplitude Healthcare Acquisition Corp (6)
ANAPTYSBIO INC (17)
ANAVEX LIFE SCIENCES CORP. (9)
Anchiano Therapeutics Ltd. (5)
Anika Therapeutics (11)
Anixa Biosciences Inc (1)
Annexon, Inc. (8)
Annovis Bio, Inc. (3)
APPLIED GENETIC TECHNOLOGIES CORP (13)
Applied Molecular Transport Inc. (6)
Applied Therapeutics Inc. (6)
Aprea Therapeutics, Inc. (8)
Aptinyx Inc. (2)
Aptose Biosciences Inc. (4)
AquaBounty Technologies, Inc. (3)
AQUINOX PHARMACEUTICALS, INC (17)
Arbutus Biopharma Corp (14)
ARCA biopharma, Inc. (3)
Arcellx, Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (1)
ARENA PHARMACEUTICALS INC (7)
ARROWHEAD PHARMACEUTICALS, INC. (2)
Arsanis, Inc. (17)
Artiva Biotherapeutics, Inc. (8)
ARYA Sciences Acquisition Corp II (13)
ASSEMBLY BIOSCIENCES, INC. (25)
Atara Biotherapeutics, Inc. (17)
Athenex, Inc. (8)
ATHERSYS, INC (6)
ATOSSA GENETICS INC (7)
Atreca, Inc. (18)
aTYR PHARMA INC (7)
Aura Biosciences, Inc. (5)
Aurinia Pharmaceuticals Inc. (10)
AVEO PHARMACEUTICALS INC (1)
Avid Bioservices, Inc. (7)
Avidity Biosciences, Inc. (8)
Avita Therapeutics, Inc. (14)
AVROBIO, Inc. (18)
Axcella Health Inc. (15)
Axovant Sciences Ltd. (8)
Ayala Pharmaceuticals, Inc. (4)
AZIYO BIOLOGICS, INC. (8)
AzurRx BioPharma, Inc. (5)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (3)
BeiGene, Ltd. (14)
BELLICUM PHARMACEUTICALS, INC (19)
Benitec Biopharma Inc. (2)
BICYCLE THERAPEUTICS Ltd (13)
Big Cypress Acquisition Corp. (10)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (6)
BioAtla, Inc. (1)
BioCardia, Inc. (2)
BIOCEPT INC (12)
BIOCRYST PHARMACEUTICALS INC (5)
Biogen Inc. (25)
Biohaven Pharmaceutical Holding Co Ltd. (10)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (39)
Biomea Fusion, Inc. (4)
BioNexus Gene Lab Coporation (4)
BioRestorative Therapies, Inc. (14)
BIOSPECIFICS TECHNOLOGIES CORP (5)
Biostage, Inc. (12)
BIOTIME INC (19)
BIOVIE INC. (8)
BioXcel Therapeutics, Inc. (13)
BIOXYTRAN, INC (6)
Black Diamond Therapeutics, Inc. (11)
Blue Water Vaccines Inc. (13)
bluebird bio, Inc. (18)
Blueprint Medicines Corp (46)
Bolt Biotherapeutics, Inc. (1)
Bone Biologics Corp (3)
BRAINSTORM CELL THERAPEUTICS INC. (24)
BriaCell Therapeutics Corp. (3)
BridgeBio Pharma, Inc. (1)
BullFrog AI Holdings, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (6)
CALADRIUS BIOSCIENCES, INC. (24)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (14)
CANCER GENETICS, INC (13)
Candel Therapeutics, Inc. (9)
CAPRICOR THERAPEUTICS, INC. (12)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (3)
Capstone Therapeutics Corp. (6)
CareDx, Inc. (1)
Caribou Biosciences, Inc. (18)
CASI Pharmaceuticals, Inc. (11)
CASTLE BIOSCIENCES INC (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (40)
CATALYST PHARMACEUTICALS, INC. (12)
CEL SCI CORP (6)
Celldex Therapeutics, Inc. (37)
Cellectar Biosciences, Inc. (13)
Cellular Biomedicine Group, Inc. (13)
Celsion CORP (7)
Centessa Pharmaceuticals Ltd (8)
Century Therapeutics, Inc. (12)
CEREBAIN BIOTECH CORP. (5)
Chanticleer Holdings, Inc. (6)
Chardan Healthcare Acquisition 2 Corp. (6)
Checkmate Pharmaceuticals, Inc. (6)
Checkpoint Therapeutics, Inc. (5)
Chelsea Worldwide Inc. (4)
ChemoCentryx, Inc. (10)
CHIMERIX INC (2)
Cibus Global, Ltd. (4)
Cidara Therapeutics, Inc. (4)
CLEVELAND BIOLABS INC (12)
Clovis Oncology, Inc. (11)
CM Life Sciences III Inc. (1)
Codiak BioSciences, Inc. (5)
CohBar, Inc. (9)
Comera Life Sciences Holdings, Inc. (1)
COMPASS Pathways plc (5)
Conatus Pharmaceuticals Inc. (26)
CONCERT PHARMACEUTICALS, INC. (3)
Constellation Alpha Capital Corp. (10)
CONTRAFECT Corp (12)
Corbus Pharmaceuticals Holdings, Inc. (26)
Cortexyme, Inc. (3)
Corvus Pharmaceuticals, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
Crinetics Pharmaceuticals, Inc. (7)
CRISPR Therapeutics AG (8)
CTD HOLDINGS INC (12)
CTI BIOPHARMA CORP (10)
Cue Biopharma, Inc. (11)
Cullinan Oncology, LLC (4)
Curative Biotechnology Inc (6)
CURIS INC (24)
Cyclacel Pharmaceuticals, Inc. (17)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (19)
Cytokinetics, Incorporated (4)
CytomX Therapeutics, Inc. (3)
CYTORI THERAPEUTICS, INC. (7)
CYTRX CORP (50)
Day One Biopharmaceuticals Holding Co LLC (1)
Decibel Therapeutics, Inc. (6)
Deciphera Pharmaceuticals, Inc. (13)
DelMar Pharmaceuticals, Inc. (8)
Dermavant Sciences Ltd (4)
Dermira, Inc. (2)
Design Therapeutics, Inc. (3)
DiaMedica Therapeutics Inc. (5)
Dicerna Pharmaceuticals Inc (26)
Diffusion Pharmaceuticals Inc. (29)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (1)
DYNAVAX TECHNOLOGIES CORP (1)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (21)
Editas Medicine, Inc. (11)
Eidos Therapeutics, Inc. (4)
Eiger BioPharmaceuticals, Inc. (16)
Elevation Oncology, Inc. (5)
Eliem Therapeutics, Inc. (6)
Emerald Bioscience, Inc. (5)
Enanta Pharmaceuticals, Inc. (2)
Enochian Biosciences Inc (2)
Entasis Therapeutics Holdings Inc. (6)
Entera Bio Ltd. (5)
Entrada Therapeutics, Inc. (4)
ENZON PHARMACEUTICALS, INC. (4)
Epizyme, Inc. (6)
Erasca, Inc. (10)
Esperion Therapeutics, Inc. (24)
Evelo Biosciences, Inc. (4)
EXACT SCIENCES CORP (21)
Exelixis (2)
EXICURE, INC. (20)
FATE THERAPEUTICS INC (3)
FENNEC PHARMACEUTICALS INC. (4)
Fibrocell Science, Inc. (15)
Finch Therapeutics Group, Inc. (7)
Flex Pharma, Inc. (17)
FLUOROPHARMA MEDICAL, INC. (4)
Forma Therapeutics Holdings, Inc., (3)
Fortress Biotech, Inc. (7)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (11)
FS Development Corp. (10)
FS Development Corp. II (1)
Fusion Pharmaceuticals Inc. (10)
G1 Therapeutics, Inc. (24)
Gain Therapeutics, Inc. (8)
GALECTIN THERAPEUTICS INC (19)
Galecto Inc. (7)
Galera Therapeutics, Inc. (10)
Gamida Cell Ltd. (12)
Gemphire Therapeutics Inc. (15)
Gene Biotherapeutics, Inc. (2)
GENELUX CORP (4)
GENETHERA INC (2)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (10)
GeoVax Labs, Inc. (16)
GERON CORP (20)
Gilead Sciences (1)
Global Blood Therapeutics, Inc. (8)
GLYCOMIMETICS INC (16)
Gossamer Bio, Inc. (10)
Graphite Bio, Inc. (5)
Greenwich LifeSciences, Inc. (2)
Gritstone Oncology, Inc. (10)
GT Biopharma, Inc. (28)
GTX INC (23)
GX Acquisition Corp. (22)
HARBOR DIVERSIFIED, INC. (4)
Harpoon Therapeutics, Inc. (5)
HCW Biologics Inc. (3)
Health Sciences Acquisitions Corp (12)
HEAT BIOLOGICS, INC. (41)
HedgePath Pharmaceuticals, Inc. (7)
HEMISPHERX BIOPHARMA INC (13)
HERON THERAPEUTICS, INC. (12)
HilleVax, Inc. (6)
Hillstream BioPharma Inc. (4)
HISTOGENICS CORP (22)
Homology Medicines, Inc. (22)
HOOKIPA Pharma Inc. (5)
HUMANIGEN, INC (16)
iBio, Inc. (6)
Icosavax, Inc. (14)
IDEAYA Biosciences, Inc. (10)
IDERA PHARMACEUTICALS, INC. (15)
IGM Biosciences, Inc. (7)
Imago BioSciences, Inc. (7)
Immix Biopharma, Inc. (3)
IMMUCELL CORP (6)
IMMUNE PHARMACEUTICALS INC (6)
Immune Therapeutics, Inc. (6)
Immuneering Corp (7)
ImmunoCellular Therapeutics, Ltd. (11)
IMMUNOGEN INC (4)
Immunome Inc. (17)
IMMUNOMEDICS INC (17)
IMPEL NEUROPHARMA INC (4)
IN8BIO, INC. (10)
Incyte (11)
INFINITY PHARMACEUTICALS, INC. (1)
Inhibikase Therapeutics, Inc. (5)
Inhibrx, Inc. (13)
InMed Pharmaceuticals Inc. (14)
Inmune Bio, Inc. (4)
Innovation Pharmaceuticals Inc. (5)
INOVIO PHARMACEUTICALS, INC. (13)
Inozyme Pharma, Inc. (14)
INSMED Inc (30)
Inspyr Therapeutics, Inc. (3)
Instil Bio, Inc. (4)
Intec Parent Inc. (6)
Intec Pharma Ltd. (2)
Intellia Therapeutics, Inc. (2)
INTERCEPT PHARMACEUTICALS, INC. (24)
INTREXON CORP (3)
Intrinsic Medicine, Inc. (3)
Invitae Corp (2)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (15)
Isoray, Inc. (16)
iTeos Therapeutics, Inc. (5)
Janux Therapeutics, Inc. (6)
Jounce Therapeutics, Inc. (3)
Kadmon Holdings, Inc. (9)
KalVista Pharmaceuticals, Inc. (11)
Karuna Therapeutics, Inc. (13)
KBL MERGER CORP. IV (21)
Keros Therapeutics, Inc. (9)
Kezar Life Sciences, Inc. (8)
Kindred Biosciences, Inc. (17)
Kiniksa Pharmaceuticals, Ltd. (13)
Kinnate Biopharma Inc. (5)
Kiromic Biopharma, Inc. (15)
KIWA BIO-TECH PRODUCTS GROUP CORP (6)
Kodiak Sciences Inc. (4)
Krystal Biotech, Inc. (9)
Kura Oncology, Inc. (20)
Kymera Therapeutics, Inc. (1)
LA JOLLA PHARMACEUTICAL CO (13)
Lantern Pharma Inc. (12)
LEAP THERAPEUTICS, INC. (13)
Leisure Acquisition Corp. (6)
LianBio (6)
LifeSci Acquisition Corp. (7)
Ligand Pharmaceuticals Incorporated (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (7)
Locust Walk Acquisition Corp. (4)
LogicBio Therapeutics, Inc. (9)
LONGEVERON LLC (3)
MACROGENICS INC (9)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (7)
MAIA Biotechnology, Inc. (8)
MANHATTAN SCIENTIFICS INC (1)
MARIZYME INC (9)
Marker Therapeutics, Inc. (11)
MATEON THERAPEUTICS INC (34)
Matinas BioPharma Holdings, Inc. (15)
MEDICINOVA INC (11)
Medovex Corp. (10)
MEI Pharma, Inc. (6)
MeiraGTx Holdings plc (5)
MERRIMACK PHARMACEUTICALS INC (16)
Merus N.V. (5)
Metacrine, Inc. (3)
Millendo Therapeutics, Inc. (17)
MiMedx Group, Inc. (17)
Minerva Neurosciences, Inc. (6)
MiNK Therapeutics, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (26)
Mirati Therapeutics, Inc. (7)
Moderna, Inc. (1)
Molecular Templates, Inc. (9)
Moleculin Biotech, Inc. (4)
Momenta Pharmaceuticals, Inc. (11)
Monopar Therapeutics (20)
Monte Rosa Therapeutics, Inc. (8)
MUSTANG BIO, INC. (2)
MYMETICS CORP (1)
Myovant Sciences Ltd. (12)
Myriad Genetics, Inc. (7)
NANOVIRICIDES, INC. (12)
NantKwest, Inc. (4)
Natera, Inc. (9)
NAVIDEA BIOPHARMACEUTICALS, INC. (20)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROCRINE BIOSCIENCES INC (9)
NEUROTROPE BIOSCIENCE, INC. (1)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (27)
NexImmune, Inc. (8)
NextCure, Inc. (6)
Nkarta, Inc. (8)
NORTHWEST BIOTHERAPEUTICS INC (5)
NOVAVAX INC (28)
Novus Therapeutics, Inc. (9)
NTN BUZZTIME INC (27)
Nuo Therapeutics, Inc. (12)
Nurix Therapeutics, Inc. (6)
Nuvalent, Inc. (3)
Nuvectis Pharma, Inc. (10)
Ohr Pharmaceutical Inc (12)
Olivia Ventures, Inc. (4)
Omega Therapeutics, Inc. (8)
OncBioMune Pharmaceuticals, Inc (7)
OncoCyte Corp (10)
Oncorus, Inc. (7)
ONCOSEC MEDICAL Inc (9)
OPGEN INC (4)
Ophthotech Corp. (2)
Opko Health, Inc. (4)
ORAGENICS INC (13)
Orchard Therapeutics plc (6)
Organicell Regenerative Medicine, Inc. (24)
ORGANOVO HOLDINGS, INC. (5)
Orgenesis Inc. (12)
Oric Pharmaceuticals, Inc. (3)
Outlook Therapeutics, Inc. (6)
Ovid Therapeutics Inc. (11)
Oyster Point Pharma, Inc. (3)
PALATIN TECHNOLOGIES INC (7)
Pasithea Therapeutics Corp. (3)
Passage BIO, Inc. (14)
PepGen Inc. (5)
Petra Acquisition Inc. (2)
Pfenex Inc. (8)
PharmaCyte Biotech, Inc. (1)
Phio Pharmaceuticals Corp. (4)
PIERIS PHARMACEUTICALS, INC. (10)
PLURISTEM THERAPEUTICS INC (7)
PMV Pharmaceuticals, Inc. (6)
POLARITYTE, INC. (21)
Poseida Therapeutics, Inc. (8)
Praxis Precision Medicines, Inc. (7)
PRECISION BIOSCIENCES INC (18)
PREDICTIVE TECHNOLOGY GROUP, INC. (4)
Prelude Therapeutics Inc (10)
PREMIER BIOMEDICAL INC (2)
Prevail Therapeutics Inc. (4)
Principia Biopharma Inc. (7)
Progenics Pharmaceuticals, Inc. (7)
Prometheus Biosciences, Inc. (5)
ProMIS Neurosciences Inc. (3)
Propanc Biopharma, Inc. (6)
Protagenic Therapeutics, Inc. (15)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (10)
PROTEON THERAPEUTICS INC (8)
PROTEOSTASIS THERAPEUTICS, INC. (7)
Prothena Corp plc (2)
PTC THERAPEUTICS, INC. (17)
PUMA BIOTECHNOLOGY, INC. (2)
Pyxis Oncology, Inc. (6)
Radius Health, Inc. (10)
Rallybio Corp (3)
RECURSION PHARMACEUTICALS, INC. (6)
Regeneron Pharmaceuticals (3)
REGENERX BIOPHARMACEUTICALS INC (5)
REGENXBIO Inc. (3)
Regulus Therapeutics Inc. (11)
Relay Therapeutics, Inc. (1)
Reneo Pharmaceuticals, Inc. (7)
RenovaCare, Inc. (3)
Repare Therapeutics Inc. (5)
Replimune Group, Inc. (12)
Retrophin, Inc. (20)
Revolution Medicines, Inc. (6)
REXAHN PHARMACEUTICALS, INC. (29)
Rezolute, Inc. (15)
RHYTHM PHARMACEUTICALS, INC. (2)
Rich Pharmaceuticals, Inc. (3)
RIGEL PHARMACEUTICALS INC (2)
RITTER PHARMACEUTICALS INC (4)
Rubius Therapeutics, Inc. (9)
Sana Biotechnology, Inc. (7)
SANGAMO THERAPEUTICS, INC (16)
Sarepta Therapeutics, Inc. (27)
Savara Inc (11)
Scholar Rock Holding Corp (8)
SEATTLE GENETICS INC (38)
SELECTA BIOSCIENCES INC (20)
SELLAS Life Sciences Group, Inc. (32)
Sensei Biotherapeutics, Inc. (12)
SERA PROGNOSTICS, INC. (20)
Seres Therapeutics, Inc. (34)
Sesen Bio, Inc. (10)
Shattuck Labs, Inc. (14)
Shuttle Pharmaceuticals Holdings, Inc. (6)
Sierra Oncology, Inc. (4)
Silverback Therapeutics, Inc. (6)
Social Capital Suvretta Holdings Corp. III (2)
SOLENO THERAPEUTICS INC (7)
Solid Biosciences Inc. (11)
SOLIGENIX, INC. (15)
SOPHIRIS BIO INC. (4)
Sorrento Therapeutics, Inc. (7)
Spectrum Pharmaceuticals, Inc. (10)
Spero Therapeutics, Inc. (11)
SPHERIX INC (14)
Spring Bank Pharmaceuticals, Inc. (3)
SpringWorks Therapeutics, Inc. (13)
SPRUCE BIOSCIENCES, INC. (3)
SQZ Biotechnologies Co (9)
Stellar Biotechnologies, Inc. (14)
Stoke Therapeutics, Inc. (9)
Summit Therapeutics Inc. (2)
Sun BioPharma, Inc. (18)
SUNESIS PHARMACEUTICALS INC (7)
Sunshine Biopharma, Inc (2)
Surface Oncology, Inc. (7)
Syndax Pharmaceuticals Inc (29)
SYNLOGIC, INC. (9)
Synthetic Biologics, Inc. (23)
T2 Biosystems, Inc. (13)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TENAX THERAPEUTICS, INC. (15)
Tenaya Therapeutics, Inc. (4)
TG THERAPEUTICS, INC. (7)
Therapeutics Acquisition Corp. (10)
Tocagen Inc (10)
Tonix Pharmaceuticals Holding Corp. (16)
Tracon Pharmaceuticals, Inc. (11)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (5)
TREVENA INC (31)
Trovagene, Inc. (14)
TScan Therapeutics, Inc. (9)
Turning Point Therapeutics, Inc. (10)
Twist Bioscience Corp (6)
TYME TECHNOLOGIES, INC. (2)
Tyra Biosciences, Inc. (16)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (4)
Unicycive Therapeutics, Inc. (3)
uniQure N.V. (18)
United Therapeutics Corp (13)
Unity Biotechnology, Inc. (15)
Unum Therapeutics Inc. (15)
UroGen Pharma Ltd. (11)
Vaccitech plc (1)
Vanda Pharmaceuticals Inc. (17)
Vaxart, Inc. (4)
Vaxcyte, Inc. (4)
VBI Vaccines Inc (3)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (3)
Verastem, Inc. (14)
Vericel Corp (24)
Vertex Pharmaceuticals Inc (23)
Verve Therapeutics, Inc. (5)
VICAL INC (9)
Vicapsys Life Sciences, Inc. (1)
Viela Bio, Inc. (3)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (15)
Vir Biotechnology, Inc. (9)
Virios Therapeutics, LLC (5)
VistaGen Therapeutics, Inc. (5)
VITAL THERAPIES INC (14)
VITRO DIAGNOSTICS INC (5)
Voyager Therapeutics, Inc. (20)
vTv Therapeutics Inc. (11)
Werewolf Therapeutics, Inc. (7)
WINDTREE THERAPEUTICS INC (33)
XBiotech Inc. (1)
Xencor Inc (8)
Xenetic Biosciences, Inc. (4)
Xenon Pharmaceuticals Inc. (17)
Xilio Therapeutics, Inc. (4)
XOMA Corp (25)
Y-mAbs Therapeutics, Inc. (7)
YIELD10 BIOSCIENCE, INC. (9)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (6)
Zai Lab Ltd (3)
Zentalis Pharmaceuticals, LLC (20)
ZIOPHARM ONCOLOGY INC (24)
Zymeworks Inc. (7)

Recent Contracts

Amendment to Employment Agreement by and between Proteomedix and Christian Brhlmann (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Amendment to Employment Agreement, dated October 16, 2020, by and between Proteomedix and Christian Brhlmann (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Form of Employment Agreement with Christian Brhlmann (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Amendment to Employment Agreement by and between Proteomedix and Ralph Schiess (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Amendment to Employment Agreement, dated October 15, 2020, by and between Proteomedix and Ralph Schiess (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Form of Employment Agreement with Ralph Schiess (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Form of Sixth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Corbus Pharmaceuticals Holdings, Inc., Filed With SEC on April 10, 2024)
Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Corbus Pharmaceuticals Holdings, Inc., Filed With SEC on April 10, 2024)
Employment Agreement, by and between the Company and Gene Mack, effective as of April 8, 2024 (Gain Therapeutics, Inc., Filed With SEC on April 8, 2024)
Employment Agreement, dated April 1, 2024, by and between the Company and Kaitlin Kestenberg (ADMA BIOLOGICS, INC., Filed With SEC on April 2, 2024)
Employment Agreement, dated September 5, 2023, by and between the Registrant and Katarina Luptakova, M.D (Xilio Therapeutics, Inc., Filed With SEC on April 1, 2024)
Executive Employment Agreement, dated as of December 29, 2021, between BioRestorative Therapies, Inc. and Robert Paccasassi (BioRestorative Therapies, Inc., Filed With SEC on April 1, 2024)
Executive Employment Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Robert Kristal (BioRestorative Therapies, Inc., Filed With SEC on April 1, 2024)
Employment Letter with Heather Rees Dated October 6, 2023 (ATOSSA GENETICS INC, Filed With SEC on April 1, 2024)
Employment Agreement with Greg Weaver Dated June 1, 2023 (ATOSSA GENETICS INC, Filed With SEC on April 1, 2024)
Employment Agreement, dated as of March 28, 2024, by and between the Registrant and Metin Kurtoglu, M.D., Ph.D (SELECTA BIOSCIENCES INC, Filed With SEC on April 1, 2024)
Employment Agreement, dated as of March 26, 2024, by and between the Registrant and Christopher Jewell, Ph.D (SELECTA BIOSCIENCES INC, Filed With SEC on April 1, 2024)
First Amendment to Amended and Restated Executive Employment Agreement dated as of May 1, 2020, by and between Trevena, Inc. and Carrie L. Bourdow (TREVENA INC, Filed With SEC on April 1, 2024)
Amended and Restated Executive Employment Agreement dated as of May 1, 2020, by and between Trevena, Inc. and Carrie L. Bourdow (TREVENA INC, Filed With SEC on April 1, 2024)
Amendment No. 4 to Employment Agreement, effective as of August 1, 2022 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 1, 2024)
Amendment No. 3 to Employment Agreement, effective as of May 1, 2020 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 1, 2024)
Amendment No. 2 to Employment Agreement, effective as of April 1, 2019 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 1, 2024)
Amendment No. 1 to Employment Agreement, effective as of March 1, 2015 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 1, 2024)
Employment Agreement, dated as of December 23, 2012 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 1, 2024)
Amendment to the Employment Agreement between the Company and Kristi (YIELD10 BIOSCIENCE, INC., Filed With SEC on April 1, 2024)
Amendment to the Employment Agreement between the Company and Lynne (YIELD10 BIOSCIENCE, INC., Filed With SEC on April 1, 2024)
Amendment to the Employment Agreement between the Company and Charles B. Haaser dated December 6, 2023 (YIELD10 BIOSCIENCE, INC., Filed With SEC on April 1, 2024)
Amendment to the Employment Agreement between the Company and Oliver (YIELD10 BIOSCIENCE, INC., Filed With SEC on April 1, 2024)
Form of Amendment to Employment Offer Letter, dated March 26, 2024 (Acorda Therapeutics, Filed With SEC on April 1, 2024)
Employment Agreement by and between Joshua Reed and the Registrant, dated April 28, 2022 (Omega Therapeutics, Inc., Filed With SEC on March 28, 2024)
Employment Agreement, dated as of (Centessa Pharmaceuticals Ltd, Filed With SEC on March 28, 2024)
Employment Agreement, dated as of (Centessa Pharmaceuticals Ltd, Filed With SEC on March 28, 2024)
Employment Agreement by and between the Registrant and Julie Green, dated January 24, 2024 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Employment Agreement by and between the Registrant and Robert Allen, dated March 14, 2023 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Employment Agreement by and between the Registrant and Stacy Price, dated February 3, 2023 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
First Amendment to the Employment Agreement of Peter Schmidt by and between the Registrant and Peter Schmidt, dated December 6, 2022 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Employment Agreement by and between the Registrant and Peter Schmidt, dated November 9, 2020 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Executive Employment Agreement by and between the Eliem Therapeutics, Inc. and James B. Bucher, effective October 1, 2020 (Eliem Therapeutics, Inc., Filed With SEC on March 28, 2024)
Executive Employment Agreement by and between Kirk V. Shephard, M.D. and PDS Biotechnology Corporation, effective as of January 22, 2024 (Edge Therapeutics, Inc., Filed With SEC on March 28, 2024)
Executive Employment Agreement by and between Lars Boesgaard and PDS Biotechnology Corporation, effective as of November 28, 2023 (Edge Therapeutics, Inc., Filed With SEC on March 28, 2024)